Equity in genetic newborn screening. (8th December 2019)

• Record Type: Journal Article
• Authors: El Hajj, Hussein; Bish, Douglas R.; Bish, Ebru K.
• Other Names: Gupta Diwakar guestEditor.
• Is Part Of: Naval research logistics. Volume 68:Number 1(2021)
• Page Start: 44
• Page End: 64
• Publication Date: 2019-12-08
• Subjects: cystic fibrosis -- equity -- genetic testing -- newborn screening -- panel design; Logistics, Naval -- Periodicals; Supplies and stores -- Periodicals; 359.07
• DOI: 10.1002/nav.21882
• Languages: English
• ISSNs: 0894-069X

Abstract

Abstract: State‐level newborn screening allows for early treatment of genetic disorders, which can substantially improve health outcomes for newborns. As the cost of genetic testing decreases, it is becoming an essential part of newborn screening. A genetic disorder can be caused by many mutation variants; therefore, an important decision is to determine which variants to search for (ie, the panel design), under a testing budget. The frequency of variants that cause a disorder and the incidence of the disorder vary by racial/ethnic group. Consequently, it is important to consider equity issues in panel design, so as to reduce disparities among different groups. We study the panel design problem using cystic fibrosis (CF) as a model disorder, considering the trade‐offs between equity and accuracy, under a limited budget. Most states use a genetic test in their CF screening protocol, but panel designs vary, and, due to cost, no state's panel includes all CF‐causing variants. We develop models that design equitable genetic testing panels, and compare them with panels that maximize sensitivity in the general population. Our case study, based on realistic CF data, highlights the value of equitable panels and provides important insight for newborn screening practices.